Concourse Financial Group Securities’s iRadimed IRMD Stock Holding History

Concourse Financial Group Securities’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-244	Closed	-$14.5K	–	1053
2024 Q4	$14.5K	Buy	244 +13	+6%	+$684	﹤0.01%	1631
2024 Q3	$11.6K	Buy	231 +3	+1%	+$138	﹤0.01%	1656
2024 Q2	$10K	Buy	228 +8	+4%	+$340	﹤0.01%	1693
2024 Q1	$9.68K	Buy	+220	New	+$9.72K	﹤0.01%	1717
2022 Q2	–	Sell	-73	Closed	-$2.62K	–	2245
2022 Q1	$3K	Sell	73 -55	-43%	-$2.54K	﹤0.01%	1959
2021 Q4	$6K	Hold	128	–	–	﹤0.01%	2000
2021 Q3	$4K	Hold	128	–	–	﹤0.01%	2124
2021 Q2	$4K	Buy	+128	New	+$3.53K	﹤0.01%	2090
2020 Q4	–	Sell	-243	Closed	-$5.62K	–	2328
2020 Q3	$5K	Buy	243 +9	+4%	+$202	﹤0.01%	1791
2020 Q2	$5K	Buy	+234	New	+$5.02K	﹤0.01%	1680

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Concourse Financial Group Securities's IRMD Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of iRadimed (IRMD) in Q1 2025, closing a stake of 244 shares — an estimated $14.5K sold.

Concourse Financial Group Securities first reported a position in IRMD in Q2 2020 and held it in 10 quarters. The position peaked at $14.5K in Q4 2024. 168 funds tracked by Wall St. Rank hold IRMD as of Q1 2025.

Concourse Financial Group Securities reported no remaining iRadimed position as of Q1 2025 after selling out during the quarter.
Concourse Financial Group Securities sold 244 iRadimed shares in Q1 2025, an estimated $14.5K.
Concourse Financial Group Securities first reported a position in iRadimed in Q2 2020 and held it in 10 quarters.
Concourse Financial Group Securities's iRadimed position peaked at $14.5K in Q4 2024.
168 funds tracked by Wall St. Rank held iRadimed as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.